Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | POLB | P06746 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30365889 | 1.00 | ALDH1A1 (0.52) | ALDH1A1POLBKDM4ETDP1L3MBTL1 | |
| SCHEMBL7199637 | 1.00 | ALDH1A1 (0.52) | ALDH1A1POLBKDM4ETDP1L3MBTL1 | |
| SCHEMBL31242688 | 0.84 | LMNA (0.54) | ALDH1A1POLBKDM4ETDP1L3MBTL1 | |
| SCHEMBL1418594 | 0.84 | LMNA (0.54) | ALDH1A1POLBKDM4ETDP1L3MBTL1 | |
| Isomyristicin SCHEMBL30678763 | 0.83 | ALDH1A1 (0.52) | ALDH1A1POLBKDM4ETDP1L3MBTL1 | |
| SCHEMBL15681760 | 0.82 | ALDH1A1 (0.67) | ALDH1A1POLBKDM4ETDP1L3MBTL1 | |
| SCHEMBL5334967 | 0.81 | ALDH1A1 (0.51) | ALDH1A1POLBKDM4ETDP1L3MBTL1 | |
| SCHEMBL5334970 | 0.81 | ALDH1A1 (0.51) | ALDH1A1POLBKDM4ETDP1L3MBTL1 | |
| SCHEMBL14294591 | 0.81 | ALDH1A1 (0.51) | ALDH1A1POLBKDM4ETDP1L3MBTL1 | |
| SCHEMBL7309566 | 0.80 | KDM4E (0.80) | ALDH1A1POLBKDM4ETDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240392220-A1 | BRANDY REPLICAS | AVA FOOD LABS, INC. | 2024-11-28 | — | — | US | disclosed |
| CN-118339274-A | Brandy replica | 艾娃食品实验室股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-6566557-B2 | Oxidation of a phenylpropane compound | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-05-20 | — | — | US | disclosed |
| US-20020133045-A1 | Process for the preparation of substituted trans-cinnamaldehyde, a natural yellow dye, from phenylpropane derivatives | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-09-19 | — | — | US | disclosed |
| WO-2002072709-A1 | A PROCESS FOR THE PREPARATION OF SUBSTITUTED TRANS-CINNAMALDEHYDE, A NATURAL YELLOW DYE, FROM PHENYLPROPANE DERIVATIVES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020133045-A1 | Process for the preparation of substituted trans-cinnamaldehyde, a natural yellow dye, from phenylpropane derivatives | CBR3, DDT, DHODH | ALDH1A1 1048/4885POLB 1313/4885KDM4E 1136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.